Patents Assigned to RENOVION, INC.
  • Patent number: 12097238
    Abstract: This disclosure provides pharmaceutical preparations, products, and methods relating to ARINA-1 for use in treating patients with chronic inflammatory lung diseases, such as lung transplant, cystic fibrosis (CF), non-CF bronchiectasis, chronic obstructive pulmonary disease (COPD, and other inflammatory lung diseases.
    Type: Grant
    Filed: April 19, 2024
    Date of Patent: September 24, 2024
    Assignee: Renovion, Inc.
    Inventors: Edward J. Delaney, Carolyn Durham, Daniel W. Copeland
  • Patent number: 11890315
    Abstract: The application is directed a composition comprising organic acid (e.g., ascorbic acid), glutathione, a glutathione derivative, a glutathione conjugate, a pharmaceutically-acceptable salt thereof, or any combination thereof, and methods of using the same. In certain aspects the application is directed to glutathione, a glutathione derivative, a glutathione conjugate, a pharmaceutically-acceptable salt thereof; and an organic acid; wherein the molar ratio is about 0.5-1:1. The composition can further comprises a bicarbonate salt, wherein the molar ratio is about 0.1-0.5:0.5-1:1.
    Type: Grant
    Filed: October 7, 2022
    Date of Patent: February 6, 2024
    Assignee: RENOVION, INC.
    Inventors: Dan Copeland, Carolyn Durham
  • Patent number: 11602555
    Abstract: The application is directed to a method of inhibiting or reducing growth of clinical isolate bacteria comprising contacting the clinical isolate with a composition comprising glutathione, a glutathione derivative, a glutathione conjugate, a pharmaceutically-acceptable salt thereof, or any combination thereof.
    Type: Grant
    Filed: November 17, 2017
    Date of Patent: March 14, 2023
    Assignee: RENOVION, INC.
    Inventors: Dan Copeland, Carolyn Durham, Thomas E. Richardson
  • Patent number: 11497786
    Abstract: The application is directed a composition comprising organic acid (e.g., ascorbic acid), glutathione, a glutathione derivative, a glutathione conjugate, a pharmaceutically-acceptable salt thereof, or any combination thereof, and methods of using the same. In certain aspects the application is directed to glutathione, a glutathione derivative, a glutathione conjugate, a pharmaceutically-acceptable salt thereof; and an organic acid; wherein the molar ratio is about 0.5-1:1. The composition can further comprises a bicarbonate salt, wherein the molar ratio is about 0.1-0.5:0.5-1:1.
    Type: Grant
    Filed: November 16, 2018
    Date of Patent: November 15, 2022
    Assignee: RENOVION, INC.
    Inventors: Dan Copeland, Carolyn Durham